Scientists Find a Potential Cure for Chronic Hepatitis B
A new drug has essentially cured 1 in 5 patients with chronic hepatitis B infections, researchers reported on…
Novo Nordisk shells out $4.7 billion up front for liver disease firm
Seven years after the biotechnology firm launched, Akero Therapeutics is slated to be acquired by the Danish…